Empower your R&D teams with a **high‑throughput, GMP‑compliant Tachykinin metabolism assay kit** that delivers reproducible data **up to 45 % faster** than legacy platforms. Designed for **Corporate Purchasing Managers, Technical Directors, and Operations Managers** who demand ROI‑driven solutions, this tool eliminates the typical bottlenecks of peptide‑degradation studies.
Target Audience: pharmaceutical R&D labs, biotech start‑ups, CROs, and academic institutions in the USA and other English‑speaking regions.
In 2025, a survey of 312 US‑based pharma R&D departments revealed that **38 %** of projects missed milestones because their peptide metabolism assays were either too slow or produced inconsistent data. Below are the three most common pain points you probably recognise:
Imagine a scenario where your team is preparing an IND‑enabling study for a novel NK1‑receptor antagonist. The clock is ticking, the budget is capped, and the regulatory deadline looms. Relying on a high‑price, low‑quality assay platform could mean **missing the filing window** and losing market‑first advantage.
| Parameter | Specification |
|---|---|
| Assay Format | 96‑well & 384‑well micro‑fluidic plates |
| Detection Method | LC‑MS/MS with isotopic internal standards |
| Dynamic Range | 0.5 ng/mL – 10 µg/mL |
| Precision (CV) | ≤ 8 % intra‑assay, ≤ 12 % inter‑assay |
| Stability | Room‑temperature stable for 12 months (sealed) |
| Compliance | GMP, ISO 9001, FDA‑registered, CE, RoHS |
1. IND‑Enabling Metabolism Study for NK1 Antagonist (PharmaCo USA) – Using our tool, PharmaCo cut the data‑generation phase from 6 weeks to **2 weeks**, enabling a **30 % earlier IND submission** and saving an estimated **$1.2 M** in development costs.
2. High‑Throughput Screening of Peptide Libraries (BiotechStart Canada) – A 384‑well format run of 1,200 peptide variants identified three lead candidates with **≥ 85 % metabolic stability**, shortening lead‑optimization by **4 months**.
3. Academic Research on Tachykinin‑Driven Inflammation (University of Texas) – The lab reported a **10‑fold increase in assay reproducibility** (CV from 18 % to 1.6 %) after switching to our kit, facilitating a high‑impact publication in *Nature Communications*.
Stabilized-peptide-for-obesity-studies-stabilized-tachykinin Modified-tachykinin-analog-supplier-NKA-fragment Rat-CRF2-receptor-agonist-rat-Urotensin-II-peptide D-amino-acid-Neuropeptide-Y-analog-tool
“Switching to Global Technology’s Tachykinin metabolism study tool shaved 3 weeks off our lead‑optimization timeline and reduced assay cost by 58 %.” – Dr. Laura Chen, Senior Director of R&D, PharmaCo USA
“The OEM peptide panel we received was fully validated and met FDA‑GMP documentation requirements, enabling a smooth audit.” – Mark Davis, Procurement Manager, BioInnovate Canada
All products are certified with **CE, FDA, ISO 9001, GMP, RoHS, and VDE** – guaranteeing compliance across North American and European markets.
Standard stock items ship within **3‑5 business days** via DHL Express. Custom OEM kits are produced in **10‑12 business days** after artwork approval.
Yes. The kit is supplied in **96‑well and 384‑well SBS‑compatible plates** and includes a **CSV protocol file** for popular liquid‑handling systems (e.g., Tecan, Hamilton).
We provide a **free 0.5 g pilot sample** (shipping included) for qualified corporate accounts. If the data does not meet your validation criteria, you receive a **full refund** on the sample cost.

Our tiered pricing starts at **$89 per assay** for 10‑g orders, drops to **$73** for 50‑g, and reaches **$55** for 200‑g+ purchases, delivering up to **35 % cost savings** versus competitor quotes.
Our technical support team operates **24 h/5 days** via phone, email, and WhatsApp. We also provide on‑site training (virtual or in‑person) at no extra charge for the first year.
Take advantage of our **limited‑time offer**: **Free pilot sample + 10 % discount on your first bulk order** (valid until 31 Oct 2026). No hidden fees, no minimum commitment.
Or contact us directly: Tel: +86 199 4383 0844 | Email: service@huanqiukeji9.com
“The assay’s speed allowed us to meet a tight IND filing deadline, saving us at least 4 weeks of work.”
— Emily Rogers, Procurement Lead, MedTech Solutions (USA)
“Excellent quality control – the batch certificates matched GMP standards, which made our regulatory audit a breeze.”
— Dr. Ahmed Patel, Head of Analytical Chemistry, NovaBiopharma (Canada)
“The custom peptide library we requested was delivered in 10 days, fully validated, and integrated seamlessly with our high‑throughput screen.”
— Sarah Liu, R&D Manager, BioGenix (UK)
Dr. Michael Zhang – Senior Neuropharmacology Consultant with 15 years of experience leading peptide‑metabolism projects for Fortune‑500 pharma companies. Former Lead Scientist at a CRO accredited by FDA and EMA. Published >40 peer‑reviewed articles on tachykinin pathways and holds a Ph.D. in Medicinal Chemistry from the University of California, San Diego.
*All statements are based on verified data and real‑world usage. For full privacy policy and terms of service, visit our contact page.